Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Trading Update

25 May 2017 07:00

RNS Number : 1609G
Huntsworth PLC
25 May 2017
 

 

Huntsworth

Trading update

 

Huntsworth plc, the healthcare communications and public relations group, is today issuing the following trading update for the four months to 30 April 2017.

 

· Group's full year results to be ahead of current consensus

· Strong trading at Huntsworth Health and Red

· Grayling trading in line with management expectations helped by UK agency returning to profit

 

Trading

 

The Group traded well through the first four months of the year, led again by strong growth at Huntsworth Health. On a like for like basis Huntsworth Health's revenues increased by over 10%, with good margin performance despite ongoing investment in talent and further diversification in two of the agencies. All of Huntsworth Health's main agencies grew in the period, led by the two largest - Evoke and Apothecom - which together account for circa 80% of divisional revenue.

 

Grayling's UK business returned to profitability in the period which means that, together with its European businesses, a large part of Grayling (representing circa 70% of annual divisional revenues) is now profitable. The US and META regions, however, remain challenging. Although we expect a decline in Grayling's like for like revenues this year, the division is trading in line with management's expectations.

 

Red has performed strongly in the period with revenues up by over 10%, with a number of new client wins. Some client churn is expected in the second half of the year which will dampen the overall annual growth rate.

 

Citigate Dewe Rogerson has experienced a mixed trading period with revenues down 2% on a like for like basis. Operations in the Netherlands, Singapore and Hong Kong have performed well, but slower transactional markets in the UK and mainland China have impacted overall revenue growth and profitability and will likely weigh on the business further during the year.

 

 

Financial Position

 

The Group remains in a strong financial position, operating well within its £70m facility. Net debt at 19 May 2017 was c. £31m, in line with management expectations.

 

 

Outlook

 

As a result of the stronger growth at Health and Red along with improved prospects at Grayling, we now expect the Group's full year results to be ahead of current consensus*.

 

The Group remains focused on driving operating profit by concentrating resources on its faster growing agencies and actively managing those underperforming ones. The Board is confident of continued progress through the remainder of 2017.

 

 

*Midpoint of consensus range for Headline PBT is £19.3m

 

 

 Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Georgia Colkin

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUGPAUPMGQC
Date   Source Headline
14th Dec 20122:22 pmRNSBoard Changes
3rd Dec 20123:41 pmRNSBlocklisting Interim Review
3rd Dec 20123:37 pmRNSTotal Voting Rights
15th Nov 20127:00 amRNSInterim Management Statement
14th Nov 20123:20 pmRNSDirector/PDMR Shareholding
7th Nov 201212:40 pmRNSAdditional Listing
22nd Oct 20123:55 pmRNSHolding(s) in Company
11th Oct 201210:03 amRNSScrip Dividend Alternative
25th Sep 20124:32 pmRNSHolding(s) in Company
3rd Sep 201211:32 amRNSTotal Voting Rights
24th Aug 201210:16 amRNSHolding(s) in Company
17th Aug 201211:06 amRNSAdditional Listing
15th Aug 20127:00 amRNSInterim Results
9th Aug 20127:00 amRNSNotice of Results
1st Aug 20129:08 amRNSTotal Voting Rights
30th Jul 201211:58 amRNSHolding(s) in Company
13th Jul 20125:29 pmRNSTransaction in Own Shares
6th Jul 201211:21 amRNSDirector/PDMR Shareholding
5th Jul 20127:00 amRNSDirectorate Change
5th Jul 20127:00 amRNSDirectorate Change
3rd Jul 20129:47 amRNSAdditional Listing
29th Jun 201211:30 amRNSShare Buy-back Programme
11th Jun 201211:52 amRNSScrip Dividend Alternative
1st Jun 20129:57 amRNSBlocklisting Interim Review
18th May 201211:16 amRNSResult of AGM
18th May 20127:00 amRNSAppointment of Non-Executive Director
18th May 20127:00 amRNSInterim Management Statement
2nd May 201210:34 amRNSAnnual Information Update
18th Apr 20129:07 amRNSNotice of AGM
4th Apr 20129:00 amRNSDirector/PDMR Shareholding
3rd Apr 20127:00 amRNSPreliminary Results
1st Feb 20129:30 amRNSTotal Voting Rights
31st Jan 20122:05 pmRNSDirector/PDMR Shareholding
31st Jan 20127:00 amRNSPre Close Trading Statement
11th Jan 20127:00 amRNSTransaction in Own Shares
4th Jan 20129:18 amRNSTotal Voting Rights
21st Dec 20117:00 amRNSTransaction in Own Shares
20th Dec 20117:00 amRNSTransaction in Own Shares
19th Dec 20117:00 amRNSTransaction in Own Shares
15th Dec 20117:00 amRNSTransaction in Own Shares
14th Dec 20117:00 amRNSTransaction in Own Shares
5th Dec 20117:00 amRNSTransaction in Own Shares
2nd Dec 20117:00 amRNSTransaction in Own Shares
1st Dec 20119:28 amRNSBlocklisting Interim Review
1st Dec 20119:25 amRNSTotal Voting Rights
1st Dec 20117:00 amRNSTransaction in Own Shares
29th Nov 20117:00 amRNSTransaction in Own Shares
25th Nov 20117:00 amRNSTransaction in Own Shares
24th Nov 201110:00 amRNSAmendment: Transaction in Own Shares
24th Nov 20119:15 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.